EICHOR
● Active Not Recruiting
Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)
Condition: Opioid Use Disorder (OUD) · Sponsor: NYU Langone Health
About this study
This is a two phase study investigating combinations of pharmacological and behavioral interventions to optimize the treatment of Opioid Use Disorder (OUD). The Retention Phase will assess strategies for improving retention on buprenorphine (BUP) and extended-release injectable naltrexone (XR-NTX). The Discontinuation Phase will assess which approaches are most likely to lead to long-term success (absence of relapse), and what characteristics of participants distinguish those who can safely discontinue Medications for Opioid Use Disorder (MOUD) from those who remain at risk of relapse and should not discontinue.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (21)
| University of Arkansas for Medical Sciences (UAMS) / Center for Addiction Services and Treatment (CAST) | Little Rock, Arkansas, United States | — |
| Tarzana Treatment Centers, Inc. | Tarzana, California, United States | — |
| Liberation Programs, Inc. | Bridgeport, Connecticut, United States | — |
| Operation PAR | Clearwater, Florida, United States | — |
| Gateway Community Services | Jacksonville, Florida, United States | — |
| Aspire Health Partners | Orlando, Florida, United States | — |
| Mountain Manor / Maryland Treatment Centers | Baltimore, Maryland, United States | — |
| McLean Hospital | Belmont, Massachusetts, United States | — |
| Stanley Street Treatment and Resources, Inc. | Fall River, Massachusetts, United States | — |
| Square Medical Group, LLC | Newton, Massachusetts, United States | — |
| Gibson Center for Behavioral Change | Cape Girardeau, Missouri, United States | — |
| Dartmouth Hitchcock - ATP | Lebanon, New Hampshire, United States | — |
+ 9 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04464980